$9,699.00
In Stock
Blenrep is an innovative medicine for multiple myeloma.
A drug with a unique mechanism of action for the treatment of adults with relapsed or treatment-resistant multiple myeloma, in patients who have previously received at least 4 drugs for treatment.
Active ingredient: Belantamab mafodotin
Prescription medicine
